论文信息 - Lipid metabolism and immunosuppressive therapy in heart transplant recipients. - 字舞流文

Lipid metabolism and immunosuppressive therapy in heart transplant recipients.

T. Ben‐Gal | G. Sahar | A. Sagie | A. Kogan | M. Sauté | M. Berman | B. Vidne | Y. Shapira | D. Aravot | M. Kramer | A. Stamler

[1] N. Ichimaru,et al. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. , 2001, Atherosclerosis.

[2] P. V. Van Veldhuisen,et al. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. , 1998, Transplantation proceedings.

[3] A. del Palacio,et al. Lipid abnormalities in stable liver transplant recipients – effects of cyclosporin, tacrolimus, and steroids , 1998, Transplant international : official journal of the European Society for Organ Transplantation.

[4] N. Persson,et al. ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIA , 1995, Transplantation.

[5] J. Mann,et al. The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy. , 1990, Transplantation.